MTA1 and colorectal carcinoma: Several FTO inhibitors were previously reported [26, 27], we treated CRC cells with 5 μM and 10 μM concentrations of FB23-2 for 24 h and the MTA1 mRNA level was upregulated (Fig. 5F).